Prospective evaluation of the direct costs of prostate enucleation by the HoLEP ® laser during the learning curve period

• Published in: Progrès en urologie (Paris) Vol. 27; no. 5; p. 319
• Main Authors: Roger, M, Goris-Gbenou, M, Guillermet, A, Vial, R, Cunin, N, Tomas, J, Bourgue, L, Combe, M, Lopez, J-G, Combe, C
• Format: Journal Article
• Language: French
• Published: France 01.04.2017
• Subjects: Aged; France; Humans; Laser Therapy - economics; Lasers, Solid-State; Learning Curve; Male; Operative Time; Prospective Studies; Prostatic Diseases - economics; Prostatic Diseases - surgery; Transurethral Resection of Prostate - economics; Transurethral Resection of Prostate - education; Treatment Outcome; Coûts directs; Learning curve; Benign prostatic hypertrophy; Direct costs; Laser holmium; Courbe d’apprentissage; HoLEP; Évaluation médico-économique; Medico-economic evaluation; Hypertrophie bénigne de la prostate
• ISSN: 1166-7087
• DOI: 10.1016/j.purol.2017.03.005

Holmium laser enucleation of the prostate (HoLEP) has been shown to be effective in treating large prostates compared to prostate transurethral resection (TURP). There are no published data evaluating specifically the impact of the learning curve on the direct costs of HoLEP. The objective of this study was to evaluate the direct costs generated by the use of HoLEP laser during the learning curve period. The costs of all medical devices (DM) and drugs used, pre- and post-operative parameters during surgery have been prospectively collected between March and October 2016. A total of 32 patients were included in the study with a mean age of 70.8 years and a mean prostate volume of 68.6 cm . The mean cost of anesthesia was 39.0 € and that of drugs and DM used for surgery was 257.95 € but could reach 470.76 € in case of conversion to bipolar resection. The mean duration of enucleation and morcellation was 150minutes with a mean weight of enucleated specimens of 40.4g. The total mean duration of patient care was 197minutes at an estimated hourly cost of € 636. Despite some limitations, this study makes it possible to analyze the direct costs of the management of benign prostatic hypertrophy using HoLEP, an innovative surgical technique, and to specify that these costs are more related to bipolar conversion and voluminous adenomas especially during the learning curve. 5.